Literature DB >> 14704790

PAF-mediated pulmonary edema: a new role for acid sphingomyelinase and ceramide.

Rolf Göggel1, Supandi Winoto-Morbach, Gabriele Vielhaber, Yumiko Imai, Karsten Lindner, Lore Brade, Helmut Brade, Stefan Ehlers, Arthur S Slutsky, Stefan Schütze, Erich Gulbins, Stefan Uhlig.   

Abstract

Platelet-activating factor (PAF) induces pulmonary edema and has a key role in acute lung injury (ALI). Here we show that PAF induces pulmonary edema through two mechanisms: acid sphingomyelinase (ASM)-dependent production of ceramide, and activation of the cyclooxygenase pathway. Agents that interfere with PAF-induced ceramide synthesis, such as steroids or the xanthogenate D609, attenuate pulmonary edema formation induced by PAF, endotoxin or acid instillation. Our results identify acid sphingomyelinase and ceramide as possible therapeutic targets in acute lung injury.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14704790     DOI: 10.1038/nm977

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  91 in total

1.  NALP-3 inflammasome silencing attenuates ceramide-induced transepithelial permeability.

Authors:  Narasaiah Kolliputi; Lakshmi Galam; Prasanna Tamarapu Parthasarathy; Srinivas M Tipparaju; Richard F Lockey
Journal:  J Cell Physiol       Date:  2012-09       Impact factor: 6.384

2.  Free insulin-like growth factor binding protein-3 (IGFBP-3) reduces retinal vascular permeability in association with a reduction of acid sphingomyelinase (ASMase).

Authors:  Jennifer L Kielczewski; Sergio Li Calzi; Lynn C Shaw; Jun Cai; Xiaoping Qi; Qing Ruan; Lin Wu; Li Liu; Ping Hu; Tailoi Chan-Ling; Robert N Mames; Sue Firth; Robert C Baxter; Patric Turowski; Julia V Busik; Michael E Boulton; Maria B Grant
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-10-21       Impact factor: 4.799

Review 3.  Roles of reactive oxygen and nitrogen species in pain.

Authors:  Daniela Salvemini; Joshua W Little; Timothy Doyle; William L Neumann
Journal:  Free Radic Biol Med       Date:  2011-01-28       Impact factor: 7.376

Review 4.  Ceramide-rich platforms in transmembrane signaling.

Authors:  Branka Stancevic; Richard Kolesnick
Journal:  FEBS Lett       Date:  2010-02-20       Impact factor: 4.124

Review 5.  Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management.

Authors:  Michael A Matthay; Guy A Zimmerman
Journal:  Am J Respir Cell Mol Biol       Date:  2005-10       Impact factor: 6.914

6.  Modulation of ecto-5'-nucleotidase by phospholipids in human umbilical vein endothelial cells (HUVEC).

Authors:  Annette Pexa; Andreas Deussen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-10-22       Impact factor: 3.000

7.  Leukotrienes in acute lung injury: a potential therapeutic target?

Authors:  James A Frank; Michael A Matthay
Journal:  Am J Respir Crit Care Med       Date:  2005-08-01       Impact factor: 21.405

8.  Exogenous sphingomyelinase causes impaired intestinal epithelial barrier function.

Authors:  Jurgen Bock; Gerhard Liebisch; Joachim Schweimer; Gerd Schmitz; Gerhard Rogler
Journal:  World J Gastroenterol       Date:  2007-10-21       Impact factor: 5.742

9.  Staphylococcus aureus beta-toxin induces lung injury through syndecan-1.

Authors:  Atsuko Hayashida; Allison H Bartlett; Timothy J Foster; Pyong Woo Park
Journal:  Am J Pathol       Date:  2009-01-15       Impact factor: 4.307

Review 10.  The unexpected role of acid sphingomyelinase in cell death and the pathophysiology of common diseases.

Authors:  Eric L Smith; Edward H Schuchman
Journal:  FASEB J       Date:  2008-06-20       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.